These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26894875)

  • 1. The anticonvulsant action of the galanin receptor agonist NAX-5055 involves modulation of both excitatory- and inhibitory neurotransmission.
    Walls AB; Flynn SP; West PJ; Müller MS; Bak LK; Bulaj G; Schousboe A; White HS
    Epilepsy Res; 2016 Mar; 121():55-63. PubMed ID: 26894875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel anticonvulsant neuropeptide and galanin analogue, NAX-5055, does not alter energy and amino acid metabolism in cultured brain cells.
    Aldana BI; Waagepetersen HS; Schousboe A; White HS; Bulaj G; Walls AB
    J Neurosci Res; 2017 Nov; 95(11):2286-2296. PubMed ID: 28397993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055.
    Flynn SP; White HS
    Neuropeptides; 2015 Apr; 50():35-42. PubMed ID: 25690510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.
    Metcalf CS; Klein BD; McDougle DR; Zhang L; Kaufmann D; Bulaj G; White HS
    Epilepsia; 2017 Feb; 58(2):239-246. PubMed ID: 28098336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models.
    White HS; Scholl EA; Klein BD; Flynn SP; Pruess TH; Green BR; Zhang L; Bulaj G
    Neurotherapeutics; 2009 Apr; 6(2):372-80. PubMed ID: 19332332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.
    Robertson CR; Scholl EA; Pruess TH; Green BR; White HS; Bulaj G
    J Med Chem; 2010 Feb; 53(4):1871-5. PubMed ID: 20121116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.
    Bulaj G; Green BR; Lee HK; Robertson CR; White K; Zhang L; Sochanska M; Flynn SP; Scholl EA; Pruess TH; Smith MD; White HS
    J Med Chem; 2008 Dec; 51(24):8038-47. PubMed ID: 19053761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic properties of a peripherally acting and GalR2 receptor-preferring galanin analog in inflammatory, neuropathic, and acute pain models.
    Metcalf CS; Klein BD; McDougle DR; Zhang L; Smith MD; Bulaj G; White HS
    J Pharmacol Exp Ther; 2015 Jan; 352(1):185-93. PubMed ID: 25347995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms.
    Jequier Gygax M; Klein BD; White HS; Kim M; Galanopoulou AS
    Epilepsy Res; 2014 Jan; 108(1):98-108. PubMed ID: 24252685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of inhibitory and excitatory fast neurotransmission in the rat CNS by heavy water (D2O).
    Wakita M; Kotani N; Shoudai K; Yamaga T; Akaike N
    J Neurophysiol; 2015 Aug; 114(2):1109-18. PubMed ID: 26019316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of pentobarbital on spontaneous and evoked transmitter release from inhibitory and excitatory nerve terminals in rat CA3 neurons.
    Shin MC; Wakita M; Iwata S; Nonaka K; Kotani N; Akaike N
    Brain Res Bull; 2013 Jan; 90():10-8. PubMed ID: 23026118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.
    Metcalf CS; Smith MD; Klein BD; McDougle DR; Zhang L; Bulaj G
    Neurochem Res; 2017 Jul; 42(7):1983-1994. PubMed ID: 28382595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant enaminones depress excitatory synaptic transmission in the rat brain by enhancing extracellular GABA levels.
    Kombian SB; Edafiogho IO; Ananthalakshmi KV
    Br J Pharmacol; 2005 Aug; 145(7):945-53. PubMed ID: 15912138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin: an endogenous anticonvulsant?
    Mazarati A; Langel U; Bartfai T
    Neuroscientist; 2001 Dec; 7(6):506-17. PubMed ID: 11765128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic modulation by galanin of excitatory synaptic transmission in substantia gelatinosa neurons of adult rat spinal cord slices.
    Yue HY; Fujita T; Kumamoto E
    J Neurophysiol; 2011 May; 105(5):2337-49. PubMed ID: 21411568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor subtype-dependent galanin actions on gamma-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdala.
    Bajo M; Madamba SG; Lu X; Sharkey LM; Bartfai T; Siggins GR
    Addict Biol; 2012 Jul; 17(4):694-705. PubMed ID: 21955024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seeking a mechanism of action for the novel anticonvulsant lacosamide.
    Errington AC; Coyne L; Stöhr T; Selve N; Lees G
    Neuropharmacology; 2006 Jun; 50(8):1016-29. PubMed ID: 16620882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre- and postsynaptic activation of M-channels by a novel opener dampens neuronal firing and transmitter release.
    Peretz A; Sheinin A; Yue C; Degani-Katzav N; Gibor G; Nachman R; Gopin A; Tam E; Shabat D; Yaari Y; Attali B
    J Neurophysiol; 2007 Jan; 97(1):283-95. PubMed ID: 17050829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability.
    Fernández M; Lao-Peregrín C; Martín ED
    Epilepsia; 2010 Mar; 51(3):384-90. PubMed ID: 19732136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galanin modulates neuronal and synaptic properties in the rat supraoptic nucleus in a use and state dependent manner.
    Kozoriz MG; Kuzmiski JB; Hirasawa M; Pittman QJ
    J Neurophysiol; 2006 Jul; 96(1):154-64. PubMed ID: 16611841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.